• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Invivyd, Inc. - Common Stock (NQ:IVVD)

    0.8283 -0.0655 (-7.33%)
    Streaming Delayed Price Updated: 1:58 PM EDT, Jul 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,498,650
    Open 0.8772
    Bid (Size) 0.8281 (400)
    Ask (Size) 0.8285 (900)
    Prev. Close 0.8938
    Today's Range 0.8130 - 0.8800
    52wk Range 0.4830 - 3.070
    Shares Outstanding 109,755,624
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire

    Performance

    YTD
    -66.9%
    -66.9%
    1 Month
    -19.6%
    -19.6%
    3 Month
    -36.3%
    -36.3%
    6 Month
    -67.5%
    -67.5%
    1 Year
    +17.7%
    +17.7%

    More News

    Read More
    News headline image
    Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
    From Invivyd
    Via GlobeNewswire
    Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge ↗
    Via Chartmill
    News headline image
    Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Participate in Upcoming Investor Events
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd (IVVD) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Invivyd Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
    From Invivyd
    Via GlobeNewswire
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    News headline image
    Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Announces Presentation at the World Vaccine Congress Washington
    From Invivyd
    Via GlobeNewswire
    News headline image
    BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Invivyd (IVVD) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
    From Invivyd
    Via GlobeNewswire
    News headline image
    Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
    From Invivyd
    Via GlobeNewswire

    Frequently Asked Questions

    Is Invivyd, Inc. - Common Stock publicly traded?
    Yes, Invivyd, Inc. - Common Stock is publicly traded.
    What exchange does Invivyd, Inc. - Common Stock trade on?
    Invivyd, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Invivyd, Inc. - Common Stock?
    The ticker symbol for Invivyd, Inc. - Common Stock is IVVD on the Nasdaq Stock Market
    What is the current price of Invivyd, Inc. - Common Stock?
    The current price of Invivyd, Inc. - Common Stock is 0.8283
    When was Invivyd, Inc. - Common Stock last traded?
    The last trade of Invivyd, Inc. - Common Stock was at 07/06/26 01:58 PM ET
    What is the market capitalization of Invivyd, Inc. - Common Stock?
    The market capitalization of Invivyd, Inc. - Common Stock is 90.91M
    How many shares of Invivyd, Inc. - Common Stock are outstanding?
    Invivyd, Inc. - Common Stock has 91M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.